Strong January retail sales sent them markets soaring to a sharply higher close with the Dow surging 107 points to 20,611. Nasdaq climbed 36 points to 5,819.
On the upside
Shares of Zosano (Nasdaq: ZSAN) extended its gains.
The Patent and Trademark Office issued a favorable decision for Editas Medicine (Nasdaq: EDIT) in a patent dispute involving CRISPR/Cas9 genome editing.
Cinedigm (Nasdaq: CIDM) narrowed losses for the third quarter.
On the downside
Investors locked in profits of ZAIS Group Holdings (Nasdaq: ZAIS).
Auris Medical (Nasdaq: EARS) priced its public offering of 10 million shares of common stock at the discounted price of $0.70 per share.
World Fuel Services (NYSE: INT) disappointed with sharply lower fourth quarter earnings that fell far short of analyst expectations.
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 index climbed 11 points to 2,349. Bitcoin added $2 to $1,004.
